Long-lasting Immunosuppressive Effects of tacrolimus-loaded Micelle NK61060 in Preclinical Arthritis and Colitis Models

References

• Kino T Hatanaka H Hashimoto M et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot.40 (9), 1249–1255 (1987).
   PubMed Web of Science ®Google Scholar
• Kino T Hatanaka H Miyata S et al. FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot.40 (9), 1256–1265 (1987).
   PubMed Web of Science ®Google Scholar
• Harding MW Galat A Uehling DE Schreiber SL . A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature341 (6244), 758–760 (1989).
   PubMed Web of Science ®Google Scholar
• Liu J Farmer JD Jr. Lane WS Friedman J Weissman I Schreiber SL . Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell66 (4), 807–815 (1991).
   PubMed Web of Science ®Google Scholar
• Azzi JR Sayegh MH Mallat SG . Calcineurin inhibitors: 40 years later, can't live without …. J. Immunol.191 (12), 5785 (2013).
   PubMed Web of Science ®Google Scholar
• Mattila PS Ullman KS Fiering S et al. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J.9 (13), 4425–4433 (1990).
   PubMed Web of Science ®Google Scholar
• Flanagan WM Corthesy B Bram RJ Crabtree GR . Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature352 (6338), 803–807 (1991).
   PubMed Web of Science ®Google Scholar
• Scalea JR Levi ST Ally W Brayman KL . Tacrolimus for the prevention and treatment of rejection of solid organ transplants. Expert Rev. Clin. Immunol.12 (3), 333–342 (2016).
   PubMed Web of Science ®Google Scholar
• Lee TJ Kennedy LA . Tacrolimus: an alternative for graft-versus-host disease prevention. Ann. Pharmacother.34 (3), 377–381 (2000).
   PubMed Web of Science ®Google Scholar
• Kitahara K Kawai S . Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis. Curr. Opin. Rheumatol.19 (3), 238–245 (2007).
   PubMed Web of Science ®Google Scholar
• Meier J Sturm A . Current treatment of ulcerative colitis. World J. Gastroenterol.17 (27), 3204–3212 (2011).
   PubMed Web of Science ®Google Scholar
• Matsuoka K Saito E Fujii T et al. Tacrolimus for the treatment of ulcerative colitis. Intest. Res.13 (3), 219–226 (2015).
   PubMedGoogle Scholar
• Hannah J Casian A D'cruz D . Tacrolimus use in lupus nephritis: a systematic review and meta-analysis. Autoimmun. Rev.15 (1), 93–101 (2016).
   PubMed Web of Science ®Google Scholar
• Takahara S . Efficacy of FK506 in renal transplantation. Ann. NY. Acad. Sci.696, 235–244 (1993).
   PubMed Web of Science ®Google Scholar
• Yasuhara M Hashida T Toraguchi M et al. Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations. Transplant. Proc.27 (1), 1108–1110 (1995).
   PubMed Web of Science ®Google Scholar
• Kershner RP Fitzsimmons WE . Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation62 (7), 920–926 (1996).
   PubMed Web of Science ®Google Scholar
• Przepiorka D Nash RA Wingard JR et al. Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation. Biol. Blood Marrow Transplant.5 (2), 94–97 (1999).
   PubMedGoogle Scholar
• Undre NA Van Hooff J Christiaans M et al. Low systemic exposure to tacrolimus correlates with acute rejection. Transplant. Proc.31 (1–2), 296–298 (1999).
   PubMed Web of Science ®Google Scholar
• Nakata Y Yoshibayashi M Yonemura T et al. Tacrolimus and myocardial hypertrophy. Transplantation69 (9), 1960–1962 (2000).
   PubMed Web of Science ®Google Scholar
• Morales JM Andres A Rengel M Rodicio JL . Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation. Nephrol. Dial. Transplant.16 (Suppl. 1), 121–124 (2001).
   PubMedGoogle Scholar
• Venkataramanan R Shaw LM Sarkozi L et al. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J. Clin. Pharmacol.41 (5), 542–551 (2001).
   PubMed Web of Science ®Google Scholar
• Ogata H Matsui T Nakamura M et al. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut55 (9), 1255–1262 (2006).
   PubMed Web of Science ®Google Scholar
• Palepu S Prasad GV . New-onset diabetes mellitus after kidney transplantation: current status and future directions. World J. Diabetes6 (3), 445–455 (2015).
   PubMed Web of Science ®Google Scholar
• Tremblay S Alloway RR . Clinical evaluation of modified release and immediate release tacrolimus formulations. AAPS J.19 (5), 1332–1347 (2017).
   PubMed Web of Science ®Google Scholar
• Rodríguez-Perálvarez M Germani G Darius T Lerut J Tsochatzis E Burroughs AK . Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis. Am. J. Transplant.12 (10), 2797–2814 (2012).
   PubMedGoogle Scholar
• Iwasaki K . Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab. Pharmacokinet.22 (5), 328–335 (2007).
   PubMed Web of Science ®Google Scholar
• Provenzani A Santeusanio A Mathis E et al. Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients. World J. Gastroenterol.19 (48), 9156–9173 (2013).
   PubMed Web of Science ®Google Scholar
• Mizuno N Sugiyama Y . Drug transporters: their role and importance in the selection and development of new drugs. Drug Metab. Pharmacokinet.17 (2), 93–108 (2002).
   PubMedGoogle Scholar
• Canaparo R Finnstrom N Serpe L et al. Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum. Clin. Exp. Pharmacol. Physiol.34 (11), 1138–1144 (2007).
   PubMed Web of Science ®Google Scholar
• Lien YH . Top 10 things primary care physicians should know about maintenance immunosuppression for transplant recipients. Am. J. Med.129 (6), 568–572 (2016).
   PubMed Web of Science ®Google Scholar
• Zhang Z Kennedy H . Ulcerative colitis: current medical therapy and strategies for improving medication adherence. Eur. J. Gastroenterol. Hepatol.21 (1), 1–8 (2009).
   PubMed Web of Science ®Google Scholar
• Kannan K Ortmann RA Kimpel D . Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology12 (3), 167–181 (2005).
   PubMedGoogle Scholar
• Koizumi F Kitagawa M Negishi T et al. Novel SN-38-incorporating polymeric micelles, NK012, eradicate vascular endothelial growth factor-secreting bulky tumors. Cancer Res.66 (20), 10048–10056 (2006).
   PubMed Web of Science ®Google Scholar
• Berrih-Aknin S Panse RL Dragin N . AIRE: a missing link to explain female susceptibility to autoimmune diseases. Ann. NY. Acad. Sci.1412 (1), 21–32 (2018).
   PubMed Web of Science ®Google Scholar
• Griffiths MM Eichwald EJ Martin JH Smith CB Dewitt CW . Immunogenetic control of experimental type II collagen-induced arthritis. Arthritis Rheum.24 (6), 781–789 (1981).
   PubMedGoogle Scholar
• Meng H-C Griffiths MM Remmers EF et al. Identification of two novel female-specific non-major histocompatibility complex loci regulating collagen-induced arthritis severity and chronicity, and evidence of epistasis. Arthritis Rheum.50 (8), 2695–2705 (2004).
   PubMedGoogle Scholar
• Ali SM Ahmad A Sheikh S et al. Polyoxyl 60 hydrogenated castor oil free nanosomal formulation of immunosuppressant Tacrolimus: pharmacokinetics, safety, and tolerability in rodents and humans. Int. Immunopharmacol.10 (3), 325–330 (2010).
   PubMed Web of Science ®Google Scholar
• Hashimoto M Hirota K Yoshitomi H et al. Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J. Exp. Med.207 (6), 1135–1143 (2010).
   PubMed Web of Science ®Google Scholar
• Sakaguchi N Takahashi T Hata H et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature426 (6965), 454–460 (2003).
   PubMed Web of Science ®Google Scholar
• Melgar S Karlsson A Michaelsson E . Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol.288 (6), G1328–G1338 (2005).
   PubMed Web of Science ®Google Scholar
• Alex P Zachos NC Nguyen T et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm. Bowel Dis.15 (3), 341–352 (2009).
   PubMed Web of Science ®Google Scholar
• Okada Y Maeda N Takakura S Miyata K Koshiba M . Tacrolimus ameliorates dextran sulfate sodium-induced colitis in mice: implication of interferon-gamma and interleukin-1beta suppression. Biol. Pharm. Bull.34 (12), 1823–1827 (2011).
   PubMed Web of Science ®Google Scholar
• Bento AF Leite DFP Marcon R et al. Evaluation of chemical mediators and cellular response during acute and chronic gut inflammatory response induced by dextran sodium sulfate in mice. Biochem. Pharmacol.84 (11), 1459–1469 (2012).
   PubMed Web of Science ®Google Scholar
• Sha T Igaki K Yamasaki M Watanabe T Tsuchimori N . Establishment and validation of a new semi-chronic dextran sulfate sodium-induced model of colitis in mice. Int. Immunopharmacol.15 (1), 23–29 (2013).
   PubMed Web of Science ®Google Scholar
• Chassaing B Aitken JD Malleshappa M Vijay-Kumar M . Dextran sulfate sodium (DSS)-induced colitis in mice. Curr. Protoc. Immunol.104 (1), 15.25.1–15.25.14 (2014).
   PubMedGoogle Scholar
• Holmdahl R Lorentzen JC Lu S et al. Arthritis induced in rats with non-immunogenic adjuvants as models for rheumatoid arthritis. Immunol. Rev.184 (1), 184–202 (2001).
   PubMedGoogle Scholar
• Kamada H Goto M Matsuura S Takaoka Y Nagai H . Immunopharmacological studies on collagen-induced arthritis in dark Agouti (DA) rats. Jpn. J. Pharmacol.74 (4), 313–322 (1997).
   PubMedGoogle Scholar
• Magari K Nishigaki F Sasakawa T et al. Anti-arthritic properties of FK506 on collagen-induced arthritis in rats. Inflamm. Res.52 (12), 524–529 (2003).
   PubMed Web of Science ®Google Scholar
• Emre S Genyk Y Schluger LK et al. Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. Transpl. Int.13 (1), 73–78 (2000).
   PubMed Web of Science ®Google Scholar
• Shin S-B Cho H-Y Kim D-D Choi H-G Lee Y-B . Preparation and evaluation of tacrolimus-loaded nanoparticles for lymphatic delivery. Eur. J. Pharm. Biopharm.74 (2), 164–171 (2010).
   PubMed Web of Science ®Google Scholar
• Dane KY Nembrini C Tomei AA et al. Nano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survival. J. Control. Rel.156 (2), 154–160 (2011).
   PubMed Web of Science ®Google Scholar
• Nishioka Y Yoshino H . Lymphatic targeting with nanoparticulate system. Adv. Drug Del. Rev.47 (1), 55–64 (2001).
   PubMed Web of Science ®Google Scholar
• Thao LQ Byeon HJ Lee C et al. Pharmaceutical potential of tacrolimus-loaded albumin nanoparticles having targetability to rheumatoid arthritis tissues. Int. J. Pharm.497 (1), 268–276 (2016).
   PubMedGoogle Scholar
• Mitamura T Yamada A Hanaoka K Asano M Niwa T Seki J . Effect of pharmacokinetic profile on the pancreatic toxicity and efficacy of tacrolimus in rats. J. Toxicol. Sci.33 (5), 575–584 (2008).
   PubMed Web of Science ®Google Scholar
• Kramer BK Charpentier B Backman L et al. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized Phase III study. Am. J. Transplant.10 (12), 2632–2643 (2010).
   PubMed Web of Science ®Google Scholar
• Kuypers DR Peeters PC Sennesael JJ et al. Improved adherence to tacrolimus once-daily formulation in renal recipients: a randomized controlled trial using electronic monitoring. Transplantation95 (2), 333–340 (2013).
   PubMed Web of Science ®Google Scholar